Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Toronto Stock Exchange  >  Cardiome Pharma Corp    COM   CA14159U3010

 SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Toronto Stock Exchange
05/20/2016 05/24/2016 05/25/2016 05/26/2016 05/27/2016 Date
6.55 6.25 6.34 6.07 6.23 Last
4750 3679 4096 4550 2000 Volume
+9.17% -4.58% +1.44% -4.26% +2.64% Change
Financials ( CAD)
Sales 2016 35,7 M
EBIT 2016 -17,9 M
Net income 2016 -19,8 M
Debt 2016 -
Yield 2016 -
Sales 2017 46,2 M
EBIT 2017 -4,85 M
Net income 2017 -10,3 M
Debt 2017 -
Yield 2017 -
P/E ratio 2016 -
P/E ratio 2017
Capi. / Sales 2016 3,56x
Capi. / Sales 2017 2,76x
Capitalization 127 M
More Financials
Company
Cardiome Pharma Corp. is a specialty pharmaceutical company.It engages in the discovery, development and commercialization of cardiovascular therapies that will improve the health of patients suffering from heart disease.Cardiome has two marketed products, BRINAVESS, approved in Europe and other... 
Sector
Pharmaceuticals
Calendar
06/21 | 06:30pmShareholder meeting
More about the company
Surperformance© ratings of Cardiome Pharma Corp
Trading Rating : Investor Rating :
More Ratings
Latest news on CARDIOME PHARMA CORP
05/13 CARDIOME PHARMA : Reports First Quarter 2016 Financial Results
05/12 CARDIOME PHARMA : Announces the Launch of ESMOCARD Solution for Injection in Fra..
05/11 CARDIOME PHARMA : to Hold First Quarter 2016 Financial Results Conference Call o..
05/11 CARDIOME PHARMA : Announces Publication of Spanish Emergency Department BRINAVES..
05/06 IIROC Trade Resumption - Cardiome Pharma Corp.
05/06 CARDIOME PHARMA : IIROC Trade Resumption - COM
05/05 CARDIOME PHARMA : IIROC Trading Halt - COM
05/05 IIROC Trade Halt - Cardiome Pharma Corp.
05/05 CARDIOME PHARMA : and Allergan Announce XYDALBA(TM) (Dalbavancin) Licensing Agre..
04/28 CARDIOME PHARMA : to Present at the Bloom Burton & Co. 5th Annual Healthcare Inv..
More news
Sector news : Biopharmaceuticals
04:03p H LUNDBECK A/S : Announcement of transactions with shares and linked securities ..
03:03p JOHNSON & JOHNSON : Canadian class-action launched over Johnson & Johnsons baby ..
03:03p OPKO HEALTH : Receives Proposed/Draft Medicare Local Coverage Determination for ..
02:22p BAYER : and Université de Sherbrooke Enter License Agreement to Drive Innovation..
01:47p MERCK KGAA : Professor Frank Stangenberg-Haverkamp receives the "African Allianc..
More sector news : Biopharmaceuticals
News from SeekingAlpha
05/13 Cardiome Pharma's (CRME) CEO Bill Hunter on Q1 2016 Results - Earnings Call T..
05/13 Cardiome Pharma revenues up 29%; net loss improves by 74% in Q1
05/13 Cardiome Pharma beats by $0.15, beats on revenue
05/12 Notable earnings before Friday?s open
05/06 Cardiome inks commercialization deal for Actavis antibiotic XYDALBA; shares u..
Advertisement
Chart CARDIOME PHARMA CORP
Duration : Period :
Cardiome Pharma Corp Technical Analysis Chart | COM | CA14159U3010 | 4-Traders
Full-screen chart
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions